Immunovia AB (publ)
IMMVF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -88.1% | -35.3% | -69.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 607.8% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -24,348.6% | -21,908.9% | -12,950.4% | 960.4% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -29,452% | -45,612.2% | -41,577% | 674.7% |
| EPS Diluted | -0.008 | -0.14 | -0.24 | 0.048 |
| % Growth | 94.1% | 41.7% | -600% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |